Host cell phenotypic variability induced by trypanosomatid-parasite- released immunomodulatory factors: Physiopathological implications

Journal of Biomedicine and Biotechnology

Volumn 2004, Issue 3, 2004, Pages 167-174

  Ouaissi, Ali ^a   Ouaissi, Mehdi ^b   Tavares, Joana ^c   Cordeiro Da Silva, Anabela ^c,d  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; INOSITOL DERIVATIVE; MUCIN; PARASITE ANTIGEN; RIBOSOME PROTEIN; SIALIDASE; TC52 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CELL DEATH; CELL GROWTH; CELL METABOLISM; CELL SURVIVAL; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST CELL; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INFLAMMATION; LEISHMANIA; LEISHMANIASIS; LIFE CYCLE; NONHUMAN; PARASITE IMMUNITY; PARASITE VIRULENCE; PATHOPHYSIOLOGY; PROTEIN FAMILY; REVIEW; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

MAMMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 4644372393     PISSN: 11107243     EISSN: None     Source Type: Journal    
DOI: 10.1155/S1110724304311034     Document Type: Review

References (52)

1. Takle GB, Snary D. South American trypanosomiasis (Chagas' disease). In: Warren KS, Ed. Immunology of Parasitic Infections. Oxford: Blackwell Scientific Publications; 1993:213-236.
2. Vermelho AB, Meirelles MN. Sialoglycoconjugates in Trypanosoma cruzi-host cell interaction: possible biological models - a review. Mem Inst Oswaldo Cruz. 1994;89(1):69-79.
3. World Health Organization. Report on the consultative meeting on Leishmania/HIV co-infection. Tech. Rep. WHO/LEISH/95.35, WHO, Geneva, 1995;89:1-14.
4. Chang KP. Cellular and molecular mechanisms of intracellular symbiosis in leishmaniasis. Int Rev Cytol Suppl. 1983;14:267-305.
5. Chang KP, Chaudhuri G, Fong D. Molecular determinants of Leishmania virulence. Annu Rev Microbiol. 1990;44:499-529.
6. Alexander J, Russell DG. The interaction of Leishmania species with macrophages. Adv Parasitol. 1992;31:175-254.
7. Wilson ME, Pearson RD. Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism. J Immunol. 1986;136(12):4681-4688.
8. Ouaissi A. Role of the RGD sequence in parasite adhesion to host cells. Parasitol Today. 1988;4:169-173.
9. Ouaissi A, Capron A. Some aspects of protozoan parasite-host cell interactions with special reference to RGD-mediated recognition process. Microb Pathog. 1989;6(1):1-5.
10. Talamas-Rohana P, Wright SD, Lennartz MR, Russell DG. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins. J Immunol. 1990;144(12):4817-4824.
11. Mosser DM, Rosenthal LA. Leishmania-macrophage interactions: multiple receptors, multiple ligands and diverse cellular responses. Semin Cell Biol. 1993;4(5):315-322.
12. Mukkada AJ, Meade JC, Glaser TA, Bonventre PF. Enhanced metabolism of Leishmania donovani amastigotes at acidic pH: an adaptation for intracellular growth. Science. 1985;229(4718):1099-1101.
13. Glaser TA, Baatz JE, Kreishman GP, Mukkada AJ. pH homeostasis in Leishmania donovani amastigotes and promastigotes. Proc Natl Acad Sci USA. 1988;85(20):7602-7606.
14. Antoine JC, Prina E, Jouanne C, Bongrand P. Parasitophorous vacuoles of Leishmania amazonensis-infected macrophages maintain an acidic pH. Infect Immun. 1990;58(3):779-787.
15. Panaro MA, Panunzio M, Jirillo E, Marangi A, Brandonisio O. Parasite escape mechanisms: the role of Leishmania lipophosphoglycan on the human phagocyte functions. A review. Immunopharmacol Immunotoxicol. 1995;17(3):595-605.
16. Schneider P, Bordier C, Etges R. Membrane proteins and enzymes of Leishmania. Subcell Biochem. 1992;18:39-72.
17. Titus RG, Gueiros-Filho FJ, de Freitas LA, Beverley SM. Development of a safe live Leishmania vaccine line by gene replacement. Proc Natl Acad Sci USA. 1995;92(22):10267-10271.
18. Beverley SM. Genetic and genomic approaches to the analysis of Leishmania virulence. In: Marr J, Nilsen T, Komuniecki R, eds. Molecular and Medical Parasitology. New York, NY: Academic Press; 2003:111-122.
19. Spath GF, Lye LF, Segawa H, Sacks DL, Turco SJ, Beverley SM. Persistence without pathology in phosphoglycan-deficient Leishmania major. Science. 2003;301(5637):1241-1243.
20. Yahiaoui B, Taibi A, Ouaissi A. A Leishmania major protein with extensive homology to silent information regulator 2 of Saccharomyces cerevisiae. Gene. 1996;169(1):115-118.
21. Vergnes B, Sereno D, Madjidian-Sereno N, Lemesre JL, Ouaissi A. Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death. Gene. 2002;296(1-2):139-150.
22. Capron A, Dessaint JP. Molecular basis of host-parasite relationship: towards the definition of protective antigens. Immunol Rev. 1989;112:27-48.
23. Capron A, Camus D. Immunoregulation by parasites extracts. Springer Semin Immunopathol. 1979;2:69-77.
24. Fernandez-Gomez R, Esteban S, Gomez-Corvera R, Zoulika K, Ouaissi A. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages. J Immunol. 1998;160(7):3471-3479.
25. Cordeiro-Da-Silva A, Borges MC, Guilvard E, Ouaissi A. Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation. Infect Immun. 2001;69(11):6588-6596.
26. Ouaissi A, Guilvard E, Delneste Y, et al. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection. J Immunol. 2002;168(12):6366-6374.
27. Neal GE, Moss EJ, Manson MM. Glutathione conjugation in oncogenesis. In: Sies H, Ketterer B, eds. Glutathione Conjugation: Mechanisms and Biological Significance. London: Academic Press; 1988:281-314.
28. Ouaissi A, Ouaissi M, Sereno D. Glutathione S-transferases and related proteins from pathogenic human parasites behave as immunomodulatory factors. Immunol Lett. 2002;81(3):159-164.
29. Ouaissi A, Cordeiro-Da-Silva A, Guevara AG, Borges M, Guilvard E. Trypanosoma cruzi-induced host immune system dysfunction: a rationale for parasite immunosuppressive factor(s) encoding gene targeting. J Biomed Biotechnol. 2001;1(1):11-17.
30. Moutiez M, Aumercier M, Schöneck R, et al. Purification and characterization of a trypanothioneglutathione thioltransferase from Trypanosoma cruzi. Biochem J. 1995;310(pt 2):433-437.
31. Moutiez M, Quemeneur E, Sergheraert C, Lucas V, Tartar A, Davioud-Charvet E. Glutathione-dependent activities of Trypansoma cruzi p52 makes it a new member of the thiol: disulphide oxidoreductase family. Biochem J. 1997;322(pt 1):43-48.
32. Ouaissi A, Guevara-Espinoza A, Chabé F, Gomez-Corvera R, Taibi A. A novel and basic mechanism of immunosuppression in Chagas' disease: Trypanosoma cruzi releases in vitro and in vivo a protein which induces T cell unresponsiveness through specific interaction with cysteine and glutathione. Immunol Lett. 1995;48(3):221-224.
33. Garzon E, Borges MC, Cordeiro-Da-Silva A, et al. Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele elicits attenuated Chagas' disease in mice. Immunol Lett. 2003;89(1):67-80.
34. Fiorentino DF, Zlotnik A, Vieira P, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991;146(10): 3444-3451.
35. Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol. 1992;148(10):3133-3139.
36. Sher A, Pearce E, Kaye P. Shaping the immune response to parasites: role of dendritic cells. Curr Opin Immunol. 2003;15(4):421-429.
37. Todeschini AR, Nunes MP, Previato JO, Mendonça-Previato L, Dosreis GA. Trans-sialidase from Trypanosoma cruzi fully activates host T cells and dendritic cells. Mem Inst Oswaldo Cruz Rio de Janeiro. 2000;95(suppl II):194.
38. Campos MA, Almeida IC, Takeuchi O, et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol. 2001;167(1):416-423.
39. Borges M, Cordeiro-Da-Silva A, Sereno D, Ouaissi A. Peptide-based analysis of the amino acid sequence important to the immunoregulatory function of Trypanosoma cruzi Tc52 virulence factor. Immunology. 2003;109(1):147-155.
40. Bohme MW, Evans DA, Miles MA, Holborow EJ. Occurrence of autoantibodies to intermediate filament proteins in human visceral leishmaniasis and their induction by experimental polyclonal B-cell activation. Immunology. 1986;59(4):583-588.
41. Bunn-Moreno MM, Madeira ED, Miller K, Menezes JA, Campos-Neto A. Hypergammaglobulinaemia in Leishmania donovani infected hamsters: possible association with a polyclonal activator of B cells and with suppression of T cell function. Clin Exp Immunol. 1985;59(2):427-434.
42. Grimaldi G Jr, Tesh RB. Leishmaniases of the new world: current concepts and implications for future research. Clin Microbiol Rev. 1993;6(3):230-250.
43. Freire-de-Lima CG, Nunes MP, Corte-Real S, et al. Proapototic activity of a Trypanaosoma cruzi ceramide-containing glycolipid turned on in host macrophages by IFN-γ. J Immunol. 1998;161(9): 4909-4916.
44. Frasch AC. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol Today. 2000;16(7):282-286.
45. Leguizamon MS, Mocetti E, Garcia Rivello H, Argibay PF, Campetella O. Trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo. J Infect Dis. 1999;180(4): 1398-1402.
46. Mucci I, Hidalgo A, Mocetti E, Argibay PF, Leguizamon MS, Campetella O. Thymocyte depletion in Trypanosoma cruzi infection is mediated by transsialidase-induced apoptosis on nurse cells complex. Proc Natl Acad Sci USA. 2002;99(6):3896-3901.
47. Chuenkova MV, Pereira MA. A trypanosomal protein synergizes with the cytokines ciliary neurotrophic factor and leukemia inhibitory factor to prevent apoptosis of neuronal cells. Mol Biol Cell. 2000;11(4):1487-1498.
48. Chuenkova MV, Furnari FB, Cavenee WK, Pereira MA. Trypanosoma cruzi trans-sialidase: a potent and specific survival factor for human Schwann cells by means of phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci USA. 2001;98(17):9936-9941.
49. Moore KJ, Matlashewski G. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol. 1994;152(6):2930-2937.
50. Aga E, Katschinski DM, van Zandbergen G, et al. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J Immunol. 2002;169(2):898-905.
51. Morris SA, Tanowitz HB, Bilezikian IP, Wittner M. Modulation of host cell metabolism by Trypanosoma cruzi. Parasitol Today. 1991;7(4):82-87.
52. Mucke L, Eddleston M. Astrocytes in infectious and immune-mediated diseases of the central nervous system. FASEB J. 1993;7(13):1226-1232.